Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells
Affiliations
- PMID: 1372812
Item in Clipboard
Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells
Adv Second Messenger Phosphoprotein Res.
1992.
No abstract available
Similar articles
-
Phosphodiesterases in vascular endothelial cells.Adv Second Messenger Phosphoprotein Res. 1992;25:201-13. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1372811 No abstract available.
-
Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma.Adv Second Messenger Phosphoprotein Res. 1992;25:289-305. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1372813 Review. No abstract available.
-
Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.Biochem Pharmacol. 1988 Jun 15;37(12):2315-20. doi: 10.1016/0006-2952(88)90357-7. Biochem Pharmacol. 1988. PMID: 2455518
-
The effects of flavonoids on cyclic nucleotide phosphodiesterases.Prog Clin Biol Res. 1986;213:281-96. Prog Clin Biol Res. 1986. PMID: 3012580 Review. No abstract available.
-
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.Thromb Res. 1987 Mar 1;45(5):477-84. doi: 10.1016/0049-3848(87)90310-0. Thromb Res. 1987. PMID: 3035738
Cited by
-
Cilostazol.Drugs Aging. 1999 Jan;14(1):63-71; discussion 72-3. doi: 10.2165/00002512-199914010-00005. Drugs Aging. 1999. PMID: 10069409 Review.
-
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.Curr Neurol Neurosci Rep. 2023 May;23(5):235-262. doi: 10.1007/s11910-023-01266-2. Epub 2023 Apr 11. Curr Neurol Neurosci Rep. 2023. PMID: 37037980 Review.
-
CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial.Neurol Ther. 2025 Jun;14(3):927-948. doi: 10.1007/s40120-025-00739-5. Epub 2025 Apr 12. Neurol Ther. 2025. PMID: 40220202 Free PMC article.
-
Targeting phosphodiesterases in anti-platelet therapy.Handb Exp Pharmacol. 2012;(210):225-38. doi: 10.1007/978-3-642-29423-5_9. Handb Exp Pharmacol. 2012. PMID: 22918733 Free PMC article. Review.
-
Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities.Stroke. 2021 Oct;52(10):e635-e645. doi: 10.1161/STROKEAHA.121.035002. Epub 2021 Sep 14. Stroke. 2021. PMID: 34517768 Free PMC article. Review.